Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2783)
All Articles published online
|
Aug 21, 2005 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lin YC, Lo HM, Chen JD. Sonographic fatty liver, overweight and ischemic heart disease. World J Gastroenterol 2005; 11(31): 4838-4842 [PMID: 16097054 DOI: 10.3748/wjg.v11.i31.4838] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i31/4838.htm |
| Number | Citing Articles |
| 1 |
Tatjána Ábel, János Fehér. Non-alcoholic fatty liver disease and cardiovascular risk. Orvosi Hetilap 2008; 149(28): 1299 doi: 10.1556/oh.2008.28418
|
| 2 |
Lukasz Tanajewski, Rebecca Harris, David J Harman, Guruprasad P Aithal, Timothy R Card, Georgios Gkountouras, Vladislav Berdunov, Indra N Guha, Rachel A Elliott. Economic evaluation of a community-based diagnostic pathway to stratify adults for non-alcoholic fatty liver disease: a Markov model informed by a feasibility study. BMJ Open 2017; 7(6): e015659 doi: 10.1136/bmjopen-2016-015659
|
| 3 |
Elisabetta Bugianesi, Amalia Gastaldelli. Hepatic and Cardiac Steatosis. Heart Failure Clinics 2012; 8(4): 663 doi: 10.1016/j.hfc.2012.06.010
|
| 4 |
Armando Tripodi, Anna L. Fracanzani, Massimo Primignani, Veena Chantarangkul, Marigrazia Clerici, Pier Mannuccio Mannucci, Flora Peyvandi, Cristina Bertelli, Luca Valenti, Silvia Fargion. Procoagulant imbalance in patients with non-alcoholic fatty liver disease. Journal of Hepatology 2014; 61(1): 148 doi: 10.1016/j.jhep.2014.03.013
|
| 5 |
Si-Yuan Pan, Hang Dong, Bao-feng Guo, Yi Zhang, Zhi-Ling Yu, Wang-Fun Fong, Yi-Fan Han, Kam-Ming Ko. Effective kinetics of schisandrin B on serum/hepatic triglyceride and total cholesterol levels in mice with and without the influence of fenofibrate. Naunyn-Schmiedeberg's Archives of Pharmacology 2011; 383(6): 585 doi: 10.1007/s00210-011-0634-x
|
| 6 |
Mustafa Tarık Ağaç, Levent Korkmaz, Gökhan Çavuşoğlu, Ayşe Gül Karadeniz, Süret Ağaç, Hüseyin Bektas, Hakan Erkan, Mustafa Oguz Varol, Mehmet Bulent Vatan, Zeydin Acar, Ümit Menteşe, Şükrü Çelik. Association Between Nonalcoholic Fatty Liver Disease and Coronary Artery Disease Complexity in Patients With Acute Coronary Syndrome. Angiology 2013; 64(8): 604 doi: 10.1177/0003319713479155
|
| 7 |
Alessandra Gentili, Giulia Daviddi, Stefano De Vuono, Maria Anastasia Ricci, Francesco Di Filippo, Abdalkader Alaeddin, Massimo R. Mannarino, Marcello Boni, Gaetano Vaudo, Graziana Lupattelli. Non-alcoholic fatty liver disease fibrosis score and preclinical vascular damage in morbidly obese patients. Digestive and Liver Disease 2016; 48(8): 904 doi: 10.1016/j.dld.2016.04.004
|
| 8 |
Davide Festi, Ramona Schiumerini, Giovanni Marasco, Eleonora Scaioli, Francesca Pasqui, Antonio Colecchia. Non-invasive diagnostic approach to non-alcoholic fatty liver disease: current evidence and future perspectives. Expert Review of Gastroenterology & Hepatology 2015; 9(8): 1039 doi: 10.1586/17474124.2015.1049155
|
| 9 |
Atoosa Adibi, Majid Jaberzadeh-Ansari, Amir-Reza Dalili, Navid Omidifar, Masoumeh Sadeghi. Association between Nonalcoholic Fatty Liver Disease (NAFLD) and Coronary Artery Disease (CAD) in Patients with Angina Pectoris. Open Journal of Medical Imaging 2013; 3(03): 97 doi: 10.4236/ojmi.2013.33015
|
| 10 |
Ángel Brea, Xavier Pintó, Juan F. Ascaso, Mariano Blasco, Ángel Díaz, Pedro González-Santos, Antonio Hernández Mijares, Teresa Mantilla, Jesús Millán, Juan Pedro-Botet. Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment. (i). Nonalcoholic fatty liver disease and its association with cardiovascular disease. Clínica e Investigación en Arteriosclerosis (English Edition) 2017; 29(3): 141 doi: 10.1016/j.artere.2016.06.001
|
| 11 |
Ran Jin, Ngoc-Anh Le, Rebecca Cleeton, Xiaoyan Sun, Jessica Cruz Muños, James Otvos, Miriam B Vos. Amount of hepatic fat predicts cardiovascular risk independent of insulin resistance among Hispanic-American adolescents. Lipids in Health and Disease 2015; 14(1) doi: 10.1186/s12944-015-0038-x
|
| 12 |
I. V. Logacheva, T. A. Ryazanova, V. R. Makarova, O. V. Surnina. Non-Alcoholic Fatty Liver Disease in Cardiac Patients with Overweight and Obesity. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2019; 28(6): 27 doi: 10.22416/1382-4376-2018-28-6-27-37
|
| 13 |
Alexandra Jichitu, Simona Bungau, Ana Maria Alexandra Stanescu, Cosmin Mihai Vesa, Mirela Marioara Toma, Cristiana Bustea, Stela Iurciuc, Marius Rus, Nicolae Bacalbasa, Camelia Cristina Diaconu. Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management. Diagnostics 2021; 11(4): 689 doi: 10.3390/diagnostics11040689
|
| 14 |
Shen Chen, Hongliang Xue, Rong Huang, Ke Chen, Haoyang Zhang, Xu Chen. Associations of MAFLD and MAFLD subtypes with the risk of the incident myocardial infarction and stroke. Diabetes & Metabolism 2023; 49(5): 101468 doi: 10.1016/j.diabet.2023.101468
|
| 15 |
Luan Rodrigues Abdallah, Ricardo Cardoso de Matos, Yves Pacheco Dias March e Souza, Débora Vieira-Soares, Gabriela Muller-Machado, Priscila Pollo-Flores. Non-alcoholic Fatty Liver Disease and Its Links with Inflammation and Atherosclerosis. Current Atherosclerosis Reports 2020; 22(1) doi: 10.1007/s11883-020-0820-8
|
| 16 |
Ralph L. Widya, Renée de Mutsert, Martin den Heijer, Saskia le Cessie, Frits R. Rosendaal, J. Wouter Jukema, Johannes W. A. Smit, Albert de Roos, Hildo J. Lamb. Association between Hepatic Triglyceride Content and Left Ventricular Diastolic Function in a Population-based Cohort: The Netherlands Epidemiology of Obesity Study. Radiology 2016; 279(2): 443 doi: 10.1148/radiol.2015150035
|
| 17 |
Yu-Cheng Lin, Pau-Chung Chen. Persistent Rotating Shift Work Exposure Is a Tough Second Hit Contributing to Abnormal Liver Function Among On-Site Workers Having Sonographic Fatty Liver. Asia Pacific Journal of Public Health 2015; 27(2): NP1765 doi: 10.1177/1010539512469248
|
| 18 |
G. Targher, F. Marra, G. Marchesini. Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?. Diabetologia 2008; 51(11): 1947 doi: 10.1007/s00125-008-1135-4
|
| 19 |
Moushira Zaki, Darine Amin, Ramy Mohamed. Body composition, phenotype and central obesity indices in Egyptian women with non-alcoholic fatty liver disease. Journal of Complementary and Integrative Medicine 2021; 18(2): 385 doi: 10.1515/jcim-2020-0073
|
| 20 |
N. Yu. Tikhomirova, L. N. Eliseeva, O. I. Zhdamarova, I. G. Malkhasyan. Features of changes in the heart, blood vessels and internal organs in men with hypertension, depending on the value of the body mass index. South Russian Journal of Therapeutic Practice 2023; 4(4): 60 doi: 10.21886/2712-8156-2023-4-4-60-68
|
| 21 |
Jun Luo, Li Xu, Jiang Li, Shuiping Zhao. Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease. European Journal of Gastroenterology & Hepatology 2015; 27(3): 193 doi: 10.1097/MEG.0000000000000254
|
| 22 |
Sang Lin, Zhang Hongxia. Epidemiological survey of prevalence of fatty liver disease and its risk factors among the university staffs in Changchun city. Proceedings 2011 International Conference on Human Health and Biomedical Engineering 2011; : 1058 doi: 10.1109/HHBE.2011.6029006
|
| 23 |
Ibrahim Cetindağlı, Muammer Kara, Alpaslan Tanoglu, Veysel Ozalper, Serkan Aribal, Yusuf Hancerli, Mehmet Unal, Onur Ozarı, Serdar Hira, Mustafa Kaplan, Yusuf Yazgan. Evaluation of endothelial dysfunction in patients with nonalcoholic fatty liver disease: Association of selenoprotein P with carotid intima-media thickness and endothelium-dependent vasodilation. Clinics and Research in Hepatology and Gastroenterology 2017; 41(5): 516 doi: 10.1016/j.clinre.2017.01.005
|
| 24 |
Neeraj Bhala, Jacob George. The Burden of Non-alcoholic Fatty Liver Disease (NAFLD) in the Asia Pacific Region. Current Hepatology Reports 2015; 14(2): 77 doi: 10.1007/s11901-015-0264-8
|
| 25 |
Amreen Dinani, Arun Sanyal. Nonalcoholic fatty liver disease: implications for cardiovascular risk. Cardiovascular Endocrinology 2017; 6(2): 62 doi: 10.1097/XCE.0000000000000126
|
| 26 |
G. Musso, R. Gambino, M. Cassader. Non‐alcoholic fatty liver disease from pathogenesis to management: an update. Obesity Reviews 2010; 11(6): 430 doi: 10.1111/j.1467-789X.2009.00657.x
|
| 27 |
Melania Gaggini, Mariangela Morelli, Emma Buzzigoli, Ralph DeFronzo, Elisabetta Bugianesi, Amalia Gastaldelli. Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease. Nutrients 2013; 5(5): 1544 doi: 10.3390/nu5051544
|
| 28 |
Jae‐Hong Ryoo, Young Ju Suh, Ho Cheol Shin, Yong Kyun Cho, Joong‐Myung Choi, Sung Keun Park. Clinical association between non‐alcoholic fatty liver disease and the development of hypertension. Journal of Gastroenterology and Hepatology 2014; 29(11): 1926 doi: 10.1111/jgh.12643
|
| 29 |
Christoph F. Dietrich, Long Shi, Axel Löwe, Yi Dong, Andrej Potthoff, Zeno Sparchez, Andreas Teufel, Sabine Guth, Jonas Koch, Richard G Barr, Xin-Wu Cui. Conventional ultrasound for diagnosis of hepatic steatosis is better than believed. Zeitschrift für Gastroenterologie 2022; 60(08): 1235 doi: 10.1055/a-1491-1771
|
| 30 |
Angel Brea Hernando, José Puzo Foncillas. Enfermedad del hígado graso no alcohólico y riesgo cardiovascular. Clínica e Investigación en Arteriosclerosis 2010; 22(6): 259 doi: 10.1016/j.arteri.2010.10.004
|
| 31 |
Lisa B. VanWagner, Manali Bhave, Helen S. Te, Joe Feinglass, Lisa Alvarez, Mary E. Rinella. Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events. Hepatology 2012; 56(5): 1741 doi: 10.1002/hep.25855
|
| 32 |
Ladan Aghakhani, Neda Haghighat, Masoud Amini, Seyed Vahid Hosseini, Seyed Jalil Masoumi, Fariborz Mansour-Ghanaei. The Risk Factors of Nonalcoholic Fatty Liver Disease in Morbidly Obese Patients Undergoing Bariatric Surgery in Iran. Gastroenterology Research and Practice 2022; 2022: 1 doi: 10.1155/2022/5980390
|
| 33 |
G. Targher. Non‐alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens. Diabetic Medicine 2007; 24(1): 1 doi: 10.1111/j.1464-5491.2007.02025.x
|
| 34 |
Karlijn J. Nass, Eline H. van den Berg, Klaas Nico Faber, Tim C.M.A. Schreuder, Hans Blokzijl, Robin P.F. Dullaart. High prevalence of apolipoprotein B dyslipoproteinemias in non-alcoholic fatty liver disease: The lifelines cohort study. Metabolism 2017; 72: 37 doi: 10.1016/j.metabol.2017.04.004
|
| 35 |
Yao Zhang, Quanxin Jiang, Xingxing Liang, Qiqi Qian, Jie Xiong, Chuchu Liu, Junting Xu, Ning Wang, Ying Xu, Peihui Zhou, Sijia Lu, Qian Zhou, Yanmei Yuan, Xuemei Fan, Junli Liu, Suzhen Chen. Coagulation Factor VII Fine-tunes Hepatic Steatosis by Blocking AKT-CD36–Mediated Fatty Acid Uptake. Diabetes 2024; 73(5): 682 doi: 10.2337/db23-0814
|
| 36 |
Si-Yuan Pan, Hang Dong, Zhi-Ling Yu, Xin-Ye Zhao, Chun-Jing Xiang, Hui Wang, Wang-Fun Fong, Kam-Ming Ko. Bicyclol, a synthetic dibenzocyclooctadiene derivative, decreases hepatic lipids but increases serum triglyceride level in normal and hypercholesterolaemic mice. Journal of Pharmacy and Pharmacology 2010; 59(12): 1657 doi: 10.1211/jpp.59.12.0007
|
| 37 |
Giovanni Targher, Christopher P. Day, Enzo Bonora. Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease. New England Journal of Medicine 2010; 363(14): 1341 doi: 10.1056/NEJMra0912063
|
| 38 |
Ángel Brea, Xavier Pintó, Juan F. Ascaso, Mariano Blasco, Ángel Díaz, Pedro González-Santos, Antonio Hernández Mijares, Teresa Mantilla, Jesús Millán, Juan Pedro-Botet. Enfermedad del hígado graso no alcohólico, asociación con la enfermedad cardiovascular y tratamiento ( I ). Enfermedad del hígado graso no alcohólico y su asociación con la enfermedad cardiovascular. Clínica e Investigación en Arteriosclerosis 2017; 29(3): 141 doi: 10.1016/j.arteri.2016.06.003
|
| 39 |
Chia-Hung Chiang, Po-Hsun Huang, Fa-Po Chung, Zu-Yin Chen, Hsin-Bang Leu, Chin-Chou Huang, Tao-Cheng Wu, Jaw-Wen Chen, Shing-Jong Lin, Massimo Federici. Decreased Circulating Endothelial Progenitor Cell Levels and Function in Patients with Nonalcoholic Fatty Liver Disease. PLoS ONE 2012; 7(2): e31799 doi: 10.1371/journal.pone.0031799
|
| 40 |
Tatjána Ábel, János Fehér. Non-Alcoholic Fatty Liver Disease and Cardiovascular Risk. Hungarian Medical Journal 2008; 2(4): 509 doi: 10.1556/HMJ.2.2008.28418
|
| 41 |
Giovanni Targher, Guido Arcaro. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 2007; 191(2): 235 doi: 10.1016/j.atherosclerosis.2006.08.021
|
| 42 |
Su-Yeon Choi, Donghee Kim, Hwa Jung Kim, Jin Hwa Kang, Su Jin Chung, Min Jung Park, Young Sun Kim, Chung Hyun Kim, Seung Ho Choi, Won Kim, Yoon Jun Kim, Jung-Hwan Yoon, Hyo-Suk Lee, Sang-Heon Cho, Myung-Whun Sung, Byung-Hee Oh. The Relation Between Non-Alcoholic Fatty Liver Disease and the Risk of Coronary Heart Disease in Koreans. The American Journal of Gastroenterology 2009; 104(8): 1953 doi: 10.1038/ajg.2009.238
|
| 43 |
Maria Stepanova, Zobair M. Younossi. Independent Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease in the US Population. Clinical Gastroenterology and Hepatology 2012; 10(6): 646 doi: 10.1016/j.cgh.2011.12.039
|
| 44 |
Fernando Bril, Romina Lomonaco, Kenneth Cusi. The challenge of managing dyslipidemia in patients with nonalcoholic fatty liver disease. Clinical Lipidology 2012; 7(4): 471 doi: 10.2217/clp.12.47
|
| 45 |
Nicholas W. S. Chew, Cheng Han Ng, Mark Dhinesh Muthiah, Arun J. Sanyal. Comprehensive Review and Updates on Holistic Approach Towards Non-Alcoholic Fatty Liver Disease Management with Cardiovascular Disease. Current Atherosclerosis Reports 2022; 24(7): 515 doi: 10.1007/s11883-022-01027-5
|
| 46 |
Serge Erlinger. Do patients with nonalcoholic fatty liver disease die from their heart?. Clinics and Research in Hepatology and Gastroenterology 2011; 35(3): 163 doi: 10.1016/j.clinre.2010.12.010
|
| 47 |
Consuelo P. Vilar, Helma P. Cotrim, Gesira S. Florentino, Cibelle P.V. Barreto, André Vinicius A. Florentino, Gerson Bragagnoli, Paulo A. Schwingel. Association between nonalcoholic fatty liver disease and coronary artery disease. Revista da Associação Médica Brasileira 2013; 59(3): 290 doi: 10.1016/j.ramb.2012.11.006
|
| 48 |
Angel Brea, José Puzo. Non-alcoholic fatty liver disease and cardiovascular risk. International Journal of Cardiology 2013; 167(4): 1109 doi: 10.1016/j.ijcard.2012.09.085
|
| 49 |
Hasan Öztürk, Hasan Ali Gümrükçüoğlu, Mehmet Yaman, Aytaç Akyol, Şenay Öztürk, Serkan Akdağ, Hakkı Şimşek, Musa Şahin, Zeki Yüksel Günaydın. Hepatosteatosis and carotid intima-media thickness in patients with myocardial infarction. Journal of Medical Ultrasonics 2016; 43(1): 77 doi: 10.1007/s10396-015-0649-x
|
| 50 |
Stefano Ballestri, Dante Romagnoli, Fabio Nascimbeni, Giampiero Francica, Amedeo Lonardo. Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications. Expert Review of Gastroenterology & Hepatology 2015; 9(5): 603 doi: 10.1586/17474124.2015.1007955
|
| 51 |
Tahmineh Tavakoli, Toba Kazemi, Homa Mollaei, Fatemeh Salmani, Samira Saghafi, Ensiah Sadat Mousavi, Mahyar Mohamadifard, Gholamreza Sharifzadeh. The Relationship Between the Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) with the Severity of Coronary Artery Disease (CAD) in Patients Undergoing Coronary Artery Angiography: A Cross- Sectional Study. Iranian Red Crescent Medical Journal 2018; 20(6) doi: 10.5812/ircmj.58369
|
| 52 |
V. C. S. Srinivasarao Bandaru, Jaydip R. Chaudhury, Palle Lalitha, Somala N. Reddy, Pradeep K. Misra, Banda Balaraju, Kandadai R. Mridula. Prevalence of asymptomatic nonalcoholic fatty liver disease in nondiabetic participants: a study from south india. The Egyptian Journal of Internal Medicine 2019; 31(1): 92 doi: 10.4103/ejim.ejim_76_18
|
| 53 |
Alessandro Mantovani, Stefano Ballestri, Amedeo Lonardo, Giovanni Targher. Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease. Digestive Diseases and Sciences 2016; 61(5): 1246 doi: 10.1007/s10620-016-4040-6
|
| 54 |
Lorenzo Maroni, Luigina Guasti, Luana Castiglioni, Franca Marino, Sara Contini, Valentina Macchi, Alessandra De Leo, Giovanni Gaudio, Matteo Tozzi, Anna M. Grandi, Marco Cosentino, Achille Venco. Lipid Targets During Statin Treatment in Dyslipidemic Patients Affected by Nonalcoholic Fatty Liver Disease. The American Journal of the Medical Sciences 2011; 342(5): 383 doi: 10.1097/MAJ.0b013e318213e526
|
| 55 |
Tamaki Yamada, Mitsuru Fukatsu, Sadao Suzuki, Tsuneya Wada, Takashi Yoshida, Takashi Joh. Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup. Journal of Gastroenterology and Hepatology 2010; 25(2): 352 doi: 10.1111/j.1440-1746.2009.05998.x
|
| 56 |
Hyun Il Seo, Yong Kyun Cho, Won Young Lee, Eun Jung Rhee, Ki Chul Sung, Bum Soo Kim, Byung Ho Son, Jun Ho Shin, Kwan Joong Joo, Hyun Pyo Hong, Seoung Wan Chae, Wook Jin. Which metabolic syndrome criteria best predict the presence of non-alcoholic fatty liver disease?. Diabetes Research and Clinical Practice 2012; 95(1): 19 doi: 10.1016/j.diabres.2011.08.013
|
| 57 |
Giovanni Targher. Non-alcoholic Fatty Liver Disease and Cardiovascular Disease Risk. Current Cardiovascular Risk Reports 2010; 4(1): 32 doi: 10.1007/s12170-009-0070-3
|
| 58 |
Yu-Cheng Lin, Jong-Dar Chen, Su-Huey Lo, Pau-Chung Chen. Worksite health screening programs for predicting the development of Metabolic Syndrome in middle-aged employees: a five-year follow-up study. BMC Public Health 2010; 10(1) doi: 10.1186/1471-2458-10-747
|
| 59 |
Matthew J. Armstrong, Leon A. Adams, Ali Canbay, Wing-Kin Syn. Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology 2014; 59(3): 1174 doi: 10.1002/hep.26717
|
| 60 |
Su-Yeon Choi, Donghee Kim, Jin Hwa Kang, Min Jung Park, Young Sun Kim, Seon Hee Lim, Chung Hyeon Kim, Hyo-Suk Lee. Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease; Relation of non-alcoholic fatty liver disease to carotid atherosclerosis. The Korean Journal of Hepatology 2008; 14(1): 77 doi: 10.3350/kjhep.2008.14.1.77
|
| 61 |
Stefan Chiriac, Carol Stanciu, Irina Girleanu, Camelia Cojocariu, Catalin Sfarti, Ana-Maria Singeap, Tudor Cuciureanu, Laura Huiban, Cristina Maria Muzica, Sebastian Zenovia, Robert Nastasa, Anca Trifan, Branka Filipović. Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases: The Heart of the Matter. Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/6696857
|
| 62 |
Tamaki Yamada, Mitsuru Fukatsu, Sadao Suzuki, Takashi Yoshida, Shinkan Tokudome, Takashi Joh. Alcohol Drinking May Not Be a Major Risk Factor for Fatty Liver in Japanese Undergoing a Health Checkup. Digestive Diseases and Sciences 2010; 55(1): 176 doi: 10.1007/s10620-008-0693-0
|
| 63 |
Dandan Wang, Zequn Yin, Likun Ma, Lan Han, Yan Chen, Wenjuan Pan, Ke Gong, Yongyao Gao, Xiaoxiao Yang, Yuanli Chen, Jihong Han, Yajun Duan. Polysaccharide MCP extracted from Morchella esculenta reduces atherosclerosis in LDLR-deficient mice. Food & Function 2021; 12(11): 4842 doi: 10.1039/D0FO03475D
|
| 64 |
Vlad Ratziu, Stefano Bellentani, Helena Cortez-Pinto, Chris Day, Giulio Marchesini. A position statement on NAFLD/NASH based on the EASL 2009 special conference. Journal of Hepatology 2010; 53(2): 372 doi: 10.1016/j.jhep.2010.04.008
|
| 65 |
Llorenç Caballería, Ingrid Arteaga, Guillem Pera, Lluís Rodríguez, Alba Alumà, Maria Antònia Auladell, Pere Torán. Factores de riesgo asociados a la presencia de hígado graso no alcohólico: un estudio de casos y controles. Medicina Clínica 2013; 141(6): 233 doi: 10.1016/j.medcli.2012.11.034
|
| 66 |
Lisa B. VanWagner, Mary E. Rinella. Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease. Current Hepatology Reports 2016; 15(2): 75 doi: 10.1007/s11901-016-0295-9
|
| 67 |
Jingjing Cai, Xiao-Jing Zhang, Yan-Xiao Ji, Peng Zhang, Zhi-Gang She, Hongliang Li. Nonalcoholic Fatty Liver Disease Pandemic Fuels the Upsurge in Cardiovascular Diseases. Circulation Research 2020; 126(5): 679 doi: 10.1161/CIRCRESAHA.119.316337
|
| 68 |
Anahat Dhillon, Randolph H. Steadman. Anesthesia and Uncommon Diseases. 2012; : 162 doi: 10.1016/B978-1-4377-2787-6.00005-X
|
| 69 |
Carrie Down, Natasha Mehta, Kristen Marks. The Risk of Cardiovascular Disease, Diabetes, Liver-Related Outcomes, and Death Over 10 Years in HIV/HCV-Coinfected Patients With and Without Steatosis. AIDS Research and Human Retroviruses 2016; 32(9): 868 doi: 10.1089/aid.2016.0051
|
| 70 |
Seyed Amir Mirbagheri, Armin Rashidi, Seifollah Abdi, Daryoush Saedi, Mehdi Abouzari. Liver: an alarm for the heart?. Liver International 2007; 27(7): 891 doi: 10.1111/j.1478-3231.2007.01531.x
|
| 71 |
Ping Wang, Hua Qiang, Yan Song, Ying Dang, Hui Luan, Lifei Cao, Qing Cui, Gang Tian. Association between Nonalcoholic Fatty Liver and Gensini Score in Patients with Coronary Heart Disease: A Cross-Sectional Study. Cardiology 2019; 144(3-4): 90 doi: 10.1159/000502111
|
| 72 |
Si-Yuan Pan, Rong Yang, Hang Dong, Zhi-ling Yu, Kam-Ming Ko. Bifendate treatment attenuates hepatic steatosis in cholesterol/bile salt- and high-fat diet-induced hypercholesterolemia in mice. European Journal of Pharmacology 2006; 552(1-3): 170 doi: 10.1016/j.ejphar.2006.09.011
|
| 73 |
Hyuktae Kwon. Letter: Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease (J Obes Metab Syndr 2019;28:129-38). Journal of Obesity & Metabolic Syndrome 2020; 29(1): 76 doi: 10.7570/jomes19068
|
| 74 |
Mehmet Fatih Inci, Fuat Özkan, Bilal Ark, Ümit Erkan Vurdem, Meltem Refiker Ege, İsa Sincer, Ali Zorlu. Sonographic Evaluation for Predicting the Presence and Severity of Coronary Artery Disease. Ultrasound Quarterly 2013; 29(2): 125 doi: 10.1097/RUQ.0b013e318291580e
|
| 75 |
Lucia Pacifico, Vito Cantisani, Paolo Ricci, John F Osborn, Elisa Schiavo, Caterina Anania, Eva Ferrara, Giuliano Dvisic, Claudio Chiesa. Nonalcoholic Fatty Liver Disease and Carotid Atherosclerosis in Children. Pediatric Research 2008; 63(4): 423 doi: 10.1203/PDR.0b013e318165b8e7
|
| 76 |
Uğur Arslan, Sedat Türkoğlu, Serhat Balcioğlu, Yusuf Tavil, Tarkan Karakan, Atiye Çengel. Association between nonalcoholic fatty liver disease and coronary artery disease. Coronary Artery Disease 2007; 18(6): 433 doi: 10.1097/MCA.0b013e3282583c0d
|
| 77 |
Giovanni Targher, Lorenzo Bertolini, Stefano Rodella, Roberto Tessari, Luciano Zenari, Giuseppe Lippi, Guido Arcaro. Nonalcoholic Fatty Liver Disease Is Independently Associated With an Increased Incidence of Cardiovascular Events in Type 2 Diabetic Patients. Diabetes Care 2007; 30(8): 2119 doi: 10.2337/dc07-0349
|
| 78 |
M. Del Ben, L. Polimeni, M. Brancorsini, A. Di Costanzo, L. D'Erasmo, F. Baratta, L. Loffredo, D. Pastori, P. Pignatelli, F. Violi, M. Arca, F. Angelico. Non-alcoholic fatty liver disease, metabolic syndrome and patatin-like phospholipase domain-containing protein3 gene variants. European Journal of Internal Medicine 2014; 25(6): 566 doi: 10.1016/j.ejim.2014.05.012
|
| 79 |
Concepcion Gonzalez, Victor de Ledinghen, Julien Vergniol, Juliette Foucher, Brigitte Le Bail, Sabrina Carlier, Elisa Maury, Henri Gin, Vincent Rigalleau. Hepatic Steatosis, Carbohydrate Intake, and Food Quotient in Patients with NAFLD. International Journal of Endocrinology 2013; 2013: 1 doi: 10.1155/2013/428542
|
| 80 |
Marco Matteo Ciccone, Mariabeatrice Principi, Enzo Ierardi, Alfredo Di Leo, Gabriella Ricci, Santa Carbonara, Michele Gesualdo, Fiorella Devito, Annapaola Zito, Francesca Cortese, Pietro Scicchitano. Inflammatory bowel disease, liver diseases and endothelial function. Journal of Cardiovascular Medicine 2015; 16(1): 11 doi: 10.2459/JCM.0000000000000149
|
| 81 |
W. Nseir, A. Shalata, A. Marmor, N. Assy. Mechanisms Linking Nonalcoholic Fatty Liver Disease with Coronary Artery Disease. Digestive Diseases and Sciences 2011; 56(12): 3439 doi: 10.1007/s10620-011-1767-y
|
| 82 |
Aitana Braza‐Boïls, Josep Marí‐Alexandre, Pilar Molina, Miguel A. Arnau, Moisés Barceló‐Molina, Diana Domingo, Javier Girbes, Juan Giner, Luis Martínez‐Dolz, Esther Zorio. Deregulated hepatic microRNAs underlie the association between non‐alcoholic fatty liver disease and coronary artery disease. Liver International 2016; 36(8): 1221 doi: 10.1111/liv.13097
|
| 83 |
Nicholas W.S. Chew, Mark D. Muthiah, Arun J. Sanyal. Cardiovascular Endocrinology and Metabolism. 2023; : 137 doi: 10.1016/B978-0-323-99991-5.00003-6
|
| 84 |
Winston Dunn, Ronghui Xu, Deborah L. Wingard, Christopher Rogers, Paul Angulo, Zobair M. Younossi, Jeffrey B. Schwimmer. Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort Study. The American Journal of Gastroenterology 2008; 103(9): 2263 doi: 10.1111/j.1572-0241.2008.02034.x
|
| 85 |
Ana C. TUYAMA, Charissa Y. CHANG. Non‐alcoholic fatty liver disease. Journal of Diabetes 2012; 4(3): 266 doi: 10.1111/j.1753-0407.2012.00204.x
|
| 86 |
Quentin M. Anstee, Giovanni Targher, Christopher P. Day. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nature Reviews Gastroenterology & Hepatology 2013; 10(6): 330 doi: 10.1038/nrgastro.2013.41
|
| 87 |
Christopher J. Danford, Jorge E. Sanchez, Kathleen E. Corey. Managing the Burden of Non-NASH NAFLD. Current Hepatology Reports 2017; 16(4): 326 doi: 10.1007/s11901-017-0371-9
|
| 88 |
Nam Kyoung Seo, Hyung suk Koo, Ji‐hee Haam, Hyung Yuk Kim, Moon Jong Kim, Kyung‐Chae Park, Kye‐Seon Park, Young‐Sang Kim. Prediction of prevalent but not incident non‐alcoholic fatty liver disease by levels of serum testosterone. Journal of Gastroenterology and Hepatology 2015; 30(7): 1211 doi: 10.1111/jgh.12935
|
| 89 |
|
| 90 |
Si-Yuan Pan, Zhi-Ling Yu, Hang Dong, Chun-Jing Xiang, Wang-Fun Fong, Kam-Ming Ko. Ethanol Extract of Fructus Schisandrae Decreases Hepatic Triglyceride Level in Mice Fed with a High Fat/Cholesterol Diet, with Attention to Acute Toxicity. Evidence-Based Complementary and Alternative Medicine 2011; 2011: 1 doi: 10.1093/ecam/nep070
|
| 91 |
Alpaslan Tanoglu, Muammer Kara. Nonalcoholic fatty liver disease-related cardiovascular risk. European Journal of Gastroenterology & Hepatology 2015; 27(10): 1126 doi: 10.1097/MEG.0000000000000434
|
| 92 |
Zhao-Yan Jiang, Chen-Ying Xu, Xian-Xing Chang, Wei-Wei Li, Lu-Ying Sun, Xiao-Bo Yang, Li-Fen Yu. Fatty liver index correlates with non-alcoholic fatty liver disease, but not with newly diagnosed coronary artery atherosclerotic disease in Chinese patients. BMC Gastroenterology 2013; 13(1) doi: 10.1186/1471-230X-13-110
|
| 93 |
Javed Ahamad, Ibrahim Toufeeq, Mohammad Ahmed Khan, Muath Sh. Mohammed Ameen, Esra T. Anwer, Subha Uthirapathy, Showkat R. Mir, Javed Ahmad. Oleuropein: A natural antioxidant molecule in the treatment of metabolic syndrome. Phytotherapy Research 2019; 33(12): 3112 doi: 10.1002/ptr.6511
|
| 94 |
Chien-Hua Chen, Chiu-Kue Nien, Chi-Chieh Yang, Yung-Hsiang Yeh. Association Between Nonalcoholic Fatty Liver Disease and Coronary Artery Calcification. Digestive Diseases and Sciences 2010; 55(6): 1752 doi: 10.1007/s10620-009-0935-9
|
| 95 |
Chan Wah-Kheong, Goh Khean-Lee. Epidemiology of a fast emerging disease in the Asia-Pacific region: non-alcoholic fatty liver disease. Hepatology International 2013; 7(1): 65 doi: 10.1007/s12072-012-9384-1
|
| 96 |
Sunmi Kim, Hyuktae Kwon, Jin-Ho Park, Belong Cho, Donghee Kim, Seung-Won Oh, Cheol Min Lee, Ho-Chun Choi. A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease. BMC Gastroenterology 2012; 12(1) doi: 10.1186/1471-230X-12-69
|
| 97 |
Jae-Hong Ryoo, Woo Taek Ham, Joong-Myung Choi, Min A Kang, So Hee An, Jong-Keun Lee, Ho Cheol Shin, Sung Keun Park. Clinical Significance of Non-Alcoholic Fatty Liver Disease as a Risk Factor for Prehypertension. Journal of Korean Medical Science 2014; 29(7): 973 doi: 10.3346/jkms.2014.29.7.973
|
| 98 |
Ugur Arslan, Mustafa Yenerçağ. Relationship between non-alcoholic fatty liver disease and coronary heart disease. World Journal of Clinical Cases 2020; 8(20): 4688-4699 doi: 10.12998/wjcc.v8.i20.4688
|